These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33000988)

  • 1. RBE for proton radiation therapy - a Nordic view in the international perspective.
    Toma-Dasu I; Dasu A; Vestergaard A; Witt Nyström P; Nyström H
    Acta Oncol; 2020 Oct; 59(10):1151-1156. PubMed ID: 33000988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRoG: An independent dose and LET
    Kopp B; Fuglsang Jensen M; Mein S; Hoffmann L; Nyström H; Falk M; Haberer T; Abdollahi A; Debus J; Mairani A
    Med Phys; 2020 Oct; 47(10):5274-5286. PubMed ID: 32737870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres.
    Heuchel L; Hahn C; Pawelke J; Sørensen BS; Dosanjh M; Lühr A
    Radiother Oncol; 2022 Jul; 172():134-139. PubMed ID: 35605747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
    Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
    Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposing a Clinical Model for RBE Based on Proton Track-End Counts.
    Henthorn NT; Gardner LL; Aitkenhead AH; Rowland BC; Shin J; Smith EAK; Merchant MJ; Mackay RI; Kirkby KJ; Chaudhary P; Prise KM; McMahon SJ; Underwood TSA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):916-926. PubMed ID: 36642109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
    Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
    ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the impact of alpha/beta and LET
    Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
    Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
    Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
    Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.